FDA Approves AspireAssist Obesity Device

The U.S. Food and Drug Administration has approved a new obesity treatment device that uses a surgically-placed tube to drain a portion of the stomach contents after every meal. The Device is called AspireAssist and doctors recommend that it should not be used by patients with eating disorders, and it is not intended to be used for short durations in those who are moderately overweight. It is intended to assist in weight loss in patients aged 22 and older who are obese, with a body mass index of 35 to 55, and who have failed to achieve and maintain weight loss through non-surgical weight-loss therapy. The FDA reviewed results from a clinical trial of 111 patients treated with AspireAssist and appropriate lifestyle therapy, and 60 control patients who received only the lifestyle therapy. After one year, patients using AspireAssist lost an average of 12.1 percent of their total body weight compared to 3.6 percent for the control patients.

Tags: , , ,